Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap4.43B
Enterprise Value3.65B
P/E Ratio6.28
PEG Ratio-0.01
Price/Sales Ratio4.38
Price/Book Ratio2.35
Enterprise/Revenue4.34
Enterprise/EBITDA6.15

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.7
Operating Margin0.67
AD

Management Effectiveness

Return On Assets0.27
Return On Equity0.48

Income Statement

Revenue52.14M
Revenue/Share0.94
Gross Profit29.35M
EBITDA-142.87M
Net Income-142.2M
Diluted EPS-0.18

Balance Sheet

Total Cash1.68B
Total Cash/Share2.16
Total Debt159.78M
Total Debt/Equity0.12
Current Ratio8.28
Book Value Per Share1.73

Price History

52-Week Change-28.46
52-Week High9.29
52-Week Low3.98
Moving Average 50 Days5.54
Moving Average 200 Days5.74

Statistics

Average Volume1.97M
Shares Outstanding782.18M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD